PharMerica Corporation (PMC)
PharMerica Corporation Profit Margin: 1.12%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
PMC Profit Margin Rankings
| Overall | 32nd percentile | 2976 of 4397 |
| Sector | 35th percentile | 553 of 857 in Services |
| Industry | 25th percentile | 6 of 8 in Drug Stores |
PMC Profit Margin Range, Past 5 Years
| Minimum | -7.15% | Sep 2007 |
| Maximum | 3.17% | Sep 2008 |
| Average | 0.69% |
About Profit Margin
Profit margin represents the percentage of revenue that a company keeps as profit after accounting for fixed and variable costs. It is calculated by dividing net income by revenue. The profit margin is mainly used for internal comparisons, because acceptable profit margins vary between industries. In general, narrow profit margins indicate increased volatility. For companies with significant fixed costs, wide profit margins reduce the risk that a decline in sales will cause a net profit loss.
Displayed as a percentage, profit margin can be thought as the amount of profit that a company keeps per dollar of revenue. For example, if a company has a profit margin of 43%, the company keeps $.43 of each dollar of revenue.
Learn More
You may also be interested in these PMC related companies
PMC News
Perception, Opportunity in Volatility - Research & Analysis on BioScrip Inc. and PharMerica Corporation
May 17, 9:00AM Marketwire
May 17, 9:00AM Marketwire
PharMerica to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
May 14, 10:32AM Business Wire
May 14, 10:32AM Business Wire
PharMerica to Present at the 11th Annual JMP Securities Research Conference
May 10, 12:00PM Business Wire
May 10, 12:00PM Business Wire
PharMerica to Present at the Deutsche Bank Securities 37th Annual Health Care Conference
May 07, 2:15PM Business Wire
May 07, 2:15PM Business Wire
Listen to $PMC Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3eFJ
about 28 days ago by earningscast
about 28 days ago by earningscast
$PMC filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3aPD
about 31 days ago by MarketBrief
about 31 days ago by MarketBrief
UBS maintains a 'Neutral' on PharMerica (PMC); Q1 Preview; Is There A Hangover From OCR’s Hostile Takeover Attempt?
Apr 25, 12:35PM Street Insider
Apr 25, 12:35PM Street Insider
PharMerica Corporation to Broadcast First Quarter 2012 Results Conference Call Live on the Internet
Apr 09, 10:00AM Business Wire
Apr 09, 10:00AM Business Wire
$PMC forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/398h
about 63 days ago by RecogniaEvents
about 63 days ago by RecogniaEvents
$PMC forms bullish "Diamond Bottom" chart pattern. http://stks.co/398j
about 63 days ago by RecogniaEvents
about 63 days ago by RecogniaEvents
PharMerica to Present at the Barclays Capital 2012 Global Healthcare Conference
Mar 13, 9:45AM Business Wire
Mar 13, 9:45AM Business Wire
PharMerica to Present at Cowen & Company 32nd Annual Health Care Conference
Mar 02, 2:15PM Business Wire
Mar 02, 2:15PM Business Wire
PharMerica to Present at 2012 RBC Capital Markets’ Healthcare Conference
Feb 27, 4:00PM Business Wire
Feb 27, 4:00PM Business Wire
Omnicare Announces Expiration of Its Tender Offer to Acquire PharMerica
Feb 21, 8:05AM Thomson Reuters ONE
Feb 21, 8:05AM Thomson Reuters ONE
News related to $PMC, currently -1.4% since open: 'Omnicare rises after analyst upgrades shares' http://stks.co/2QOR
about 106 days ago by TradeBot
about 106 days ago by TradeBot
Listen to $PMC Q4 2011 earnings call - live at 10:00 AM, ondemand after - http://stks.co/2Ldv
about 111 days ago by earningscast
about 111 days ago by earningscast
$PMC Reports Q4 EPS $0.35 vs $0.21 Est; Revenues $495.6M vs $504.17M Est
about 112 days ago by Benzinga
about 112 days ago by Benzinga
PharMerica Reports Strong Results for the Fourth Quarter of 2011 and Year Ended December 31, 2011
Feb 09, 4:05PM Business Wire
Feb 09, 4:05PM Business Wire
$PMC Says Will Continue to Look for Acquisitions; Shareholders Looking for $20-25 Offer
about 135 days ago by Benzinga
about 135 days ago by Benzinga
Looking for bottoming plays? Here you go http://stks.co/1wXB $MELA $PMC $PSMT $QCOR
about 136 days ago by 1nvestor
about 136 days ago by 1nvestor
Pharmerica $PMC down 10% as FTC will likely block takeover by Omnicare $OCR
about 140 days ago by Street_Insider
about 140 days ago by Street_Insider
$PMC anyone for a clue why this is trading down? Antitrust concerns?? $OCR
about 142 days ago by ATLtrader
about 142 days ago by ATLtrader
$OCR Extends Tender Offer for $PMC Until January 20, 2012; Amends Timing Agreement with the FTC
about 178 days ago by Benzinga
about 178 days ago by Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PMC | 9.90 | -0.14 | -1.39% | 295.58M |
| PMBC | 6.15 | -0.10 | -1.60% | 76.69M |
| PMA | 27.00 | -0.16 | -0.60% | |
| PM | 84.69 | -0.19 | -0.22% | 146.15B |
| PLXT | 6.22 | -0.08 | -1.27% | 281.80M |
| PLXS | 27.60 | -0.55 | -1.95% | 979.90M |
| PLX | 6.14 | -0.21 | -3.31% | 576.71M |
| SONC | 8.27 | +0.00 | +0.00% | 500.75M |
| SON | 30.47 | -0.34 | -1.10% | 3.098B |
| SOMX | 0.30 | +0.01 | +3.45% | 13.95M |